SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation

Clinical trial NCT03454984 · UNKNOWN

Trial details

NCT number: NCT03454984
Sponsor: Groupe Francophone des Myelodysplasies
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia

Start date: 2018-11-01
Primary completion: 2020-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.